Immune cells and angiogenesis

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 A, 2009, Pages 2822-2833

  Ribatti, Domenico ^a   Crivellato, Enrico ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Antiangiogenesis; Chronic inflammation; Immune cells; Tumour growth

Indexed keywords

ANIMAL; CELL TRANSDIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNITY; IMMUNOLOGY; INFLAMMATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; STEM CELL;

ANIMALS; CELL TRANSDIFFERENTIATION; HUMANS; IMMUNITY; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 72849141569     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00810.x     Document Type: Review

References (144)

1. Ribatti D. Genetic and epigenetic mechanisms in the early development of the vascular system. J Anat. 2006 208 : 139 152.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971 285 : 1182 1186.
3. Ribatti D. Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis. 2008 11 : 3 10.
4. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996 86 : 353 364.
5. Ribatti D, Nico B, Crivellato E, et al. The history of the angiogenic switch concept. Leukemia. 2007 21 : 44 52.
6. Ribatti D, Vacca A. Overview of angiogenesis during tumor growth. In : Figg WG, Folkman J, editors. Angiogenesis. An integrative approach from science to medicine. New York : Springer 2008. pp. 161 168.
7. Mueller MM. Inflammation and angiogenesis: innate immune cells as modulators of tumor vascularization. In : Marmé D, Fusenig N, editors. Tumor angiogenesis. Basic mechanisms and cancer therapy. Berlin-Heidelberg : Springer-Verlag 2008. pp. 351 362.
8. Nyberg P, Salo T, Kalluri R. Tumor microenvironment and angiogenesis. Front Bioscience. 2008 13 : 6537 6553.
9. Ribatti D, Nico B, Vacca A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene. 2006 25 : 4257 4266.
10. Calcano G, Lee J, Kikly K, et al. Neutrophil and B cell expansion in mice that lack murine IL-8 receptor homolog. Science. 1994 265 : 682 684.
11. Devalaraja RM, Nanney LB, Qian Q, et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000 115 : 234 244.
12. Dubravec DB, Spriggs DR, Mannick JA, et al. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci USA. 1990 87 : 6758 6761.
13. Bazzoni F, Cassatella MA, Rossi F, et al. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med. 1991 173 : 771 774.
14. Grenier A, Chollet-Martin S, Crestani B, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood. 2002 99 : 2997 3004.
15. Schruefer R, Sulyok S, Schymeinsky J, et al. The proangiogenic capacity of polymorphonuclear neutrophils delineated by microarray technique and by measurement of neovascularization in wounded skin of CD18-deficient mice. J Vasc Res. 2006 43 : 1 11.
16. Ohki Y, Heissig B, Sato Y, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 2005 19 : 2005 2007.
17. Ancelin M, Chollet-Martin S, Herve MA, et al. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest. 2004 8 : 502 512.
18. Queen MM, Ryan RE, Holzer RG, et al. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 2005 65 : 8896 8904.
19. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol. 1996 3 : 895 904.
20. Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 2006 103 : 12493 12498.
21. Masson V, De La Ballina LR, Munaut C, et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. 2005 19 : 234 236.
22. Obermueller E, Vosseler S, Fusenig NE, et al. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res. 2004 64 : 7801 7812.
23. Gutschalk CM, Herold-Mende CC, Fusenig NE, et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor promote malignant growth of cells from head and neck squamous cells carcinomas in vivo. Cancer Res. 2006 66 : 8026 8036.
24. Muhs BE, Plitas G, Delgado Y, et al. Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. J Surg Res. 2003 111 : 8 15.
25. Schwartz JD, Monea S, Marcus SG, et al. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. J Surg Res. 1998 76 : 79 85.
26. Bartlett MR, Underwood PA, Parish CR. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Immunol Cell Biol. 1995 73 : 113 124.
27. Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001 189 : 197 206.
28. Chavakis T, Cines DB, Rhee JS, et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J. 2004 18 : 1306 1308.
29. Scapini P, Nesi L, Morini M, et al. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol. 2002 168 : 5798 5804.
30. Benelli R, Morini M, Carrozzino F, et al. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J. 2002 16 : 267 269.
31. Tee MK, Vigne JL, Taylor RN. All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology. 2006 147 : 1264 1270.
32. de Paulis A, Prevete N, Rossi FW, et al. Expression and functions of vascular endothelial growth factors and their receptors in human basophils. J Immunol. 2006 177 : 7322 7331.
33. Sörbo J, Jakobbson A, Norrby K. Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol. 1994 75 : 43 50.
34. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol. 1997 17 : 70 7.
35. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. Allergy Clin Immunol. 2001 107 : 295 301.
36. Wong DT, Weller PF, Galli SJ, et al. Human eosinophils express transforming growth factor alpha. J Exp Med. 1990 172 : 673 681.
37. Kita H, Ohnishi T, Okubo Y, et al. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991 174 : 745 748.
38. Solomon A, Aloe L, Pe'er J, et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol. 1998 102 : 454 460.
39. Yousefi S, Hemmann S, Weber M, et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol. 1995 154 : 5481 5490.
40. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001 107 : 295 301.
41. Feistritzer C, Kaneider NC, Sturn DH, et al. Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. Am J Respir Cell Mol Biol. 2004 30 : 729 735.
42. Puxeddu I, Alian A, Piliponsky AM, et al. Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol. 2005 37 : 628 636.
43. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002 168 : 3595 3600.
44. Puxeddu I, Berkman N, Nissim Ben Efraim AH, et al. The role of eosinophil major basic protein in angiogenesis. Allergy. 2009 64 : 368 374.
45. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow Lancet. 2001 357 : 539 545.
46. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002 23 : 549 555.
47. Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005 4 : 3 8.
48. Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006 42 : 717 727.
49. Sunderkotter C, Goebeler M, Schiltze-Osthoff K, et al. Macrophage-derived angiogenesis factors. Pharmacol Ther. 1991 51 : 195 216.
50. Lewis CE, Leek R, Harris A, et al. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol. 1995 57 : 747 751.
51. Klimp AH, Hollema H, Kempinga C, et al. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 2001 61 : 7305 7309.
52. Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996 56 : 4625 4629.
53. Makitie T, Summanen P, Takkanen A, et al. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophtalmol Vis Sci. 2001 42 : 1414 1421.
54. Nishie A, Ono M, Shono T, et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999 5 : 1107 1113.
55. Koide N, Nishio A, Sato T, et al. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol. 2004 99 : 1667 1674.
56. Hanada T, Nakagawa M, Emoto A, et al. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol. 2000 7 : 263 269.
57. Lissbrant IF, Stattin P, Wikstrom P, et al. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol. 2000 17 : 445 451.
58. Nakao S, Kuwano T, Tsutsumi-Miyahara C, et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest. 2005 115 : 2979 2991.
59. Egami K, Murohara T, Shimada T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest. 2003 112 : 67 75.
60. Lin EY, Nguyen AV, Russel RG, et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001 193 : 727 740.
61. Ohno S, Ohno Y, Suzuki N, et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 2004 24 : 3335 3342.
62. Leek RD, Landers RJ, Harris AL, et al. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer. 1999 79 : 991 995.
63. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002 196 : 254 265.
64. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995 92 : 4392 4396.
65. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast cell migration. Blood. 1995 86 : 2488 2493.
66. Denhardt DT, Noda M, O'Regan AW, et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001 107 : 1055 1061.
67. Leali D, Dell'Era P, Stabile H, et al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol. 2003 171 : 1085 1093.
68. Naldini A, Leali D, Pucci A, et al. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol. 2006 177 : 4267 4270.
69. Colombo MP, Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002 13 : 155 168.
70. Angiolillo AL, Sgadari C, Taub DD, et al. Human interferon-inducible protein 10 isa potent inhibitor of angiogenesis in vivo. J Exp Med. 1995 182 : 155 162.
71. Romagnani P, Annunziato F, Lasagni L, et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest. 2001 107 : 53 63.
72. Dias S, Boyd R, Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer. 1998 78 : 361 365.
73. Barrera P, Blom A, van Lent PL van Bloois L, et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 2000 43 : 1951 1959.
74. Zeisberger SM, Odermatt B, Marty C, et al. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new high and highly effective antiangiogenic therapy approach. Br J Cancer. 2006 95 : 272 281.
75. Aurora AB, Baluk P, Zhang D, et al. Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol. 2005 175 : 6319 6326.
76. Strasly M, Cavallo F, Guena M, et al. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol. 2001 166 : 3890 3899.
77. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005 436 : 193 200.
78. Yao L, Sgadari C, Furuke K, et al. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood. 1999 93 : 1612 1621.
79. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunology Today. 1993 14 : 335 338.
80. Cavallo F, Quaglino E, Cifaldi L, et al. Interleukin 12-activated lymphocytes influence tumor genetic programs. Cancer Res. 2001 61 : 3518 3523.
81. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000 18 : 767 811.
82. Bancherau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1988 392 : 245 252.
83. Mimura K, Kono K, Takahashi A, et al. Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol Immunother. 2007 56 : 761 770.
84. Bourbié-Vaudanie S, Blanchard N, Hivroz C, et al. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. J Immunol. 2006 177 : 1460 1469.
85. Riboldi E, Musso T, Moroni E, et al. Cuting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol. 2005 175 : 2788 2792.
86. Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+ CD11+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004 6 : 409 421.
87. Suzuki E, Kapoor V, Jassar AS, et al. Gemcitabile selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res. 2005 11 : 6713 6721.
88. Pan PY, Wang GX, Yin B, et al. Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood. 2008 111 : 219 228.
89. Kujawski M, Kortylewski M, Lee H, et al. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest. 2008 18 : 3367 3377.
90. Fernandez Pujol B, Lucibello FC, Gehling UM, et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation. 2000 65 : 287 300.
91. Schmeisser A, Garlichs CD, Zhang H, et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res. 2001 49 : 671 680.
92. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002 106 : 2019 2025.
93. Anghelina M, Krishnan P, Moldovan L, et al. Monocytes and macrophages form branched cell columns in Matrigel: implications for a role in neovascularization. Stem Cell Dev. 2004 13 : 665 676.
94. Venneri MA, De Palma M, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood. 2007 109 : 5276 5285.
95. Gottfried E, Kreutz M, Haffner S, et al. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand J Immunol. 2007 65 : 329 335.
96. Yamada T, Sawatsubashi M, Yakushiji H, et al. Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with "multi-labelling subtraction immunostaining". Virchows Arch. 1998 433 : 567 570.
97. Vento SI, Wolff CH, Salven PJ, et al. Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol Suppl. 2000 543 : 170 174.
98. Qu Z, Liebler JM, Powers MR, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. 1995 147 : 564 573.
99. Qu Z, Huang X, Ahmadi P, et al. Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int Arch Allergy Immunol. 1998a 115 : 47 54.
100. Qu Z, Kayton RJ, Ahmadi P, et al. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules. Morphological evidence for bfgf release through degranulation. J Histochem Cytochem. 1998b 46 : 1119 1128.
101. Grützkau A, Krüger-Krasagakes S, Baumeister H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/ VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell. 1998 9 : 875 884.
102. Abdel-Majid RM, Marshall JS. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol. 2004 172 : 1227 1236.
103. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998 188 : 1135 1145.
104. Kanbe N, Kurosawa M, Nagata H, et al. Production of fibrogenic cytokines by cord blood-derived cultured human mast cells. J Allergy Clin Immunol. 2000 106 : S85 S90.
105. Detmar M, Brown LF, Schon MP, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998 111 : 1 6.
106. Detoraki A, Staiano RI, Granata F, et al. Vascular endothelial growth factors syntesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol. 2009 123 : 1142 1149.
107. Ribatti D, Crivellato E, Candussio L, et al. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy. 2001 31 : 602 608.
108. Norrby K, Jakobsson A, Sörbo J. Mast cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Mol Pathol. 1986 52 : 195 206.
109. Norrby K, Jakobsson A, Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Mol Pathol. 1989 57 : 251 256.
110. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997 77 : 1033 1079.
111. Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation: tryptase is a novel potent angiogenic factor. J Clin Invest. 1997 99 : 2691 2700.
112. Ribatti D, Roncali L, Nico B, et al. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat. 1987 130 : 257 263.
113. Moller A, Lippert U, Lessmann D, et al. Human mast cells produce IL-8. J Immunol. 1993 151 : 3261 3266.
114. Walsh LJ, Trinchieri G, Waldorf HA, et al. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA. 1991 88 : 4220 4224.
115. Nilsson G, Forsberg-Nilsson K, Xiang, Z, et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol. 1997 27 : 2295 2301.
116. Aoki M, Pawankar R, Niimi Y, et al. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol. 2003 130 : 216 223.
117. Starkey JR, Crowle PK, Taubenberger S. Mast cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer. 1988 42 : 48 52.
118. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004 25 : 235 241.
119. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics. 1982 70 : 48 51.
120. Hartveit F. Mast cells and metachromasia in human breast cancer: their occurrence, significance and consequence: a preliminary report. J Pathol. 1981 134 : 7 11.
121. Bowrey PF, King J, Magarey C, et al. Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect Br J Cancer. 2000 82 : 167 170.
122. Lachter J, Stein M, Lichting C, et al. Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum. 1995 38 : 290 293.
123. Graham R, Graham J. Mast cells and cancer of the cervix. Surg Gynecol Obstet. 1966 123 : 3 9.
124. Benitez-Bribiesca L, Wong A, Utrera D, et al. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem. 2001 49 : 1061 1062.
125. Sawatsubashi M, Yamada T, Fukushima N, et al. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch B Cell Pathol Mol Pathol. 2000 436 : 243 248.
126. Imada A, Shijubo N, Koijma H, et al. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Resp J. 2000 15 : 1087 1093.
127. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 2000 88 : 2686 2692.
128. Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg. 2000 69 : 1686 1689.
129. Reed JA, McNutt NS, Bogdany JK, et al. Expression of the mast cell growth factor interleukin-3 in the melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol. 1996 23 : 495 505.
130. Dvorak AM, Mihm MC Jr., Osage JE, et al. Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol. 1980 75 : 388 393.
131. Tóth-Jakatics R, Jimi S, Takebayashi S, et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumoral accumulation of mast cells overexpressing vascular endothelial growth factor. Human Pathol. 2000 31 : 955 960.
132. Ribatti D, Vacca A, Ria R, et al. Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer. 2003 39 : 666 674.
133. Ribatti D, Ennas MG, Vacca A, et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J.Clin Invest. 2003 33 : 420 425.
134. Elpek GO, Gelen T, Aksoy NH, et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol. 2001 54 : 940 944.
135. Ribatti D, Finato N, Crivellato E, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathological progression in human endometrial cancer. Am J Obstet Gynecol. 2005 193 : 1961 1965.
136. Ribatti D, Nico B, Vacca A, et al. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas Br J Cancer. 1998 77 : 1900 1906.
137. Ribatti D, Vacca A, Marzullo A, et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer. 2002 85 : 171 175.
138. Fukushima N, Satoh T, Sano M, et al. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2001 42 : 709 720.
139. Ribatti D, Vacca A, Nico B, et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer. 1999 79 : 451 455.
140. Ribatti D, Polimero G, Vacca A, et al. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia. 2002 16 : 1680 1684.
141. Ribatti D, Molica S, Vacca A, et al. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia. 2003 17 : 1428 1430. (Pubitemid 36857360)
142. Molica S, Vacca A, Crivellato E, et al. Tryptase-positive mast cells predict clinical outcome of patients with B-cell chronic lymphocytioc leukemia. Eur J Haematol. 2003 71 : 137 139. (Pubitemid 36951650)
143. Italiano JE Jr., Richardson JL, Paltel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008 111 : 1227 1233.
144. Klement GL, Yip TT, Cassiola F, et al. Platelets actively sequester angiogenesis regulators. Blood. 2009 113 : 2835 2842.